{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:45Z","timestamp":1790352525144,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1052616"],"award-info":[{"award-number":["1052616"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1111632"],"award-info":[{"award-number":["1111632"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.redox.2021.102152","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T16:49:29Z","timestamp":1632761369000},"page":"102152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance"],"prefix":"10.1016","volume":"47","author":[{"given":"Weiyu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Tumanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8241-2903","authenticated-orcid":false,"given":"Daniel J.","family":"Fazakerley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2509-1271","authenticated-orcid":false,"given":"James","family":"Cantley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5946-5257","authenticated-orcid":false,"given":"David E.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise L.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taqi","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cacang","family":"Suarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7414-6681","authenticated-orcid":false,"given":"Roland","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2021.102152_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2021.102152_bib2","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1093\/eurheartj\/ehv350","article-title":"The role of metabolic syndrome in heart failure","volume":"36","author":"Perrone-Filardi","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.redox.2021.102152_bib3","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","article-title":"Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.redox.2021.102152_bib4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2021.102152_bib5","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2021.102152_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.102152_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.clinbiochem.2011.11.017","article-title":"Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response","volume":"45","author":"Kumar","year":"2012","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.redox.2021.102152_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3350\/cmh.2012.18.4.383","article-title":"Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease","volume":"18","author":"Kwak","year":"2012","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.redox.2021.102152_bib9","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1542\/peds.2008-3087","article-title":"Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease","volume":"124","author":"Lin","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.redox.2021.102152_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MPG.0b013e318291fefe","article-title":"Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children","volume":"57","author":"Puri","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.redox.2021.102152_bib11","first-page":"201","article-title":"High total bilirubin as a protective factor for diabetes mellitus: an analysis of NHANES data from 1999 - 2006","volume":"2","author":"Cheriyath","year":"2010","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.redox.2021.102152_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.atherosclerosis.2008.07.021","article-title":"Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents","volume":"203","author":"Lin","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.redox.2021.102152_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1753-0407.2011.00138.x","article-title":"Low serum total bilirubin concentrations are associated with increased prevalence of metabolic syndrome in Chinese","volume":"3","author":"Wu","year":"2011","journal-title":"J. Diabetes"},{"key":"10.1016\/j.redox.2021.102152_bib14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1089\/jwh.2010.2453","article-title":"Inverse association between total bilirubin and metabolic syndrome in rural Korean women","volume":"20","author":"Kwon","year":"2011","journal-title":"J. Womens Health (Larchmt)"},{"key":"10.1016\/j.redox.2021.102152_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.numecd.2011.03.001","article-title":"Relationships between serum total bilirubin levels and metabolic syndrome in Korean adults","volume":"23","author":"Choi","year":"2013","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.redox.2021.102152_bib16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.redox.2021.102152_bib17","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1073\/pnas.84.16.5918","article-title":"Antioxidant activity of albumin bound bilirubin","volume":"84","author":"Stocker","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.redox.2021.102152_bib18","doi-asserted-by":"crossref","first-page":"16712","DOI":"10.1016\/S0021-9258(19)89449-8","article-title":"Free and albumin-bound bilirubin is an efficient co-antioxidant for a-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation","volume":"269","author":"Neuzil","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.102152_bib19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.freeradbiomed.2017.11.020","article-title":"Absence of the biliverdin reductase-a gene is associated with increased endogenous oxidative stress","volume":"115","author":"Chen","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2021.102152_bib20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.20334","article-title":"Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats","volume":"40","author":"Wang","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2021.102152_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.RES.85.8.663","article-title":"Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme","volume":"85","author":"Hayashi","year":"1999","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2021.102152_bib22","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1210\/en.2013-1667","article-title":"Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation","volume":"155","author":"Dong","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.redox.2021.102152_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tem.2015.02.001","article-title":"Biliverdin reductase isozymes in metabolism","volume":"26","author":"O'Brien","year":"2015","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.redox.2021.102152_bib24","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.2174\/1389450111009011586","article-title":"Potential application of biliverdin reductase and its fragments to modulate insulin\/IGF-1\/MAPK\/PI3-K signaling pathways in therapeutic settings","volume":"11","author":"Maines","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.redox.2021.102152_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153427","article-title":"Bilirubin binding to PPAR\u03b1 inhibits lipid accumulation","volume":"11","author":"Stec","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.redox.2021.102152_bib26","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1152\/ajpendo.00396.2016","article-title":"Mice with hyperbilirubinemia due to Gilbert's syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPAR\u03b1","volume":"312","author":"Hinds","year":"2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.redox.2021.102152_bib27","doi-asserted-by":"crossref","first-page":"25179","DOI":"10.1074\/jbc.M116.731703","article-title":"Biliverdin reductase A attenuates hepatic steatosis by inhibition of glycogen synthase kinase (GSK)3\u03b2 phosphorylation of serine 73 of peroxisome proliferator-activated receptor (PPAR)\u03b1","volume":"291","author":"Hinds","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.102152_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tips.2008.12.003","article-title":"Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin","volume":"30","author":"Kapitulnik","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.redox.2021.102152_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32111","article-title":"Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance","volume":"7","author":"Fazakerley","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.redox.2021.102152_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/35055575","article-title":"Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver","volume":"409","author":"Abel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.redox.2021.102152_bib31","doi-asserted-by":"crossref","first-page":"22504","DOI":"10.1073\/pnas.0912487106","article-title":"PPAR\u03b3 activation in adipocytes is sufficient for systemic insulin sensitization","volume":"106","author":"Sugii","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.redox.2021.102152_bib32","doi-asserted-by":"crossref","first-page":"H2495","DOI":"10.1152\/ajpheart.00139.2008","article-title":"A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload","volume":"295","author":"Raher","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.redox.2021.102152_bib33","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1038\/s41467-018-07146-5","article-title":"Long term but not short term exposure to obesity related microbiota promotes host insulin resistance","volume":"9","author":"Foley","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2021.102152_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.redox.2021.102152_bib35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1172\/JCI34275","article-title":"Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice","volume":"118","author":"Postic","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2021.102152_bib36","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3109\/10715762.2012.677840","article-title":"Fatty liver induced by free radicals and lipid peroxidation","volume":"46","author":"Morita","year":"2012","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.redox.2021.102152_bib37","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1021\/ja00067a019","article-title":"Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein","volume":"115","author":"Bowry","year":"1993","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.redox.2021.102152_bib38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jchromb.2014.10.027","article-title":"Simultaneous determination of the bilirubin oxidation end products Z-BOX A and Z-BOX B in human serum using liquid chromatography coupled to tandem mass spectrometry","volume":"974","author":"Seidel","year":"2015","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.redox.2021.102152_bib39","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1046\/j.1432-1327.2000.01812.x","article-title":"Oxidative degradation of bilirubin produces vasoactive compounds","volume":"267","author":"Kranc","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.redox.2021.102152_bib40","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1742-4658.2010.07947.x","article-title":"Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans","volume":"278","author":"Wanders","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.redox.2021.102152_bib41","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1021\/bi400914c","article-title":"CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but not transport across the plasma membrane","volume":"52","author":"Xu","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.redox.2021.102152_bib42","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.amjmed.2010.01.030","article-title":"Green jaundice revisited","volume":"123","author":"McDonagh","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.redox.2021.102152_bib43","doi-asserted-by":"crossref","first-page":"5297","DOI":"10.1074\/jbc.275.8.5297","article-title":"Reaction intermediates and single turnover rate constants for the oxidation of heme by human heme oxygenase-1","volume":"275","author":"Liu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2021.102152_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/01.ATV.0000152605.64964.c0","article-title":"Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans","volume":"25","author":"Morrow","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2021.102152_bib45","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2021.102152_bib46","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2021.102152_bib47","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.0800750105","article-title":"Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling","volume":"105","author":"Lerner-Marmarosh","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.redox.2021.102152_bib48","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1096\/fj.13-247015","article-title":"Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor","volume":"28","author":"Gibbs","year":"2014","journal-title":"Faseb. J."},{"key":"10.1016\/j.redox.2021.102152_bib49","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/en.2003-1015","article-title":"Peroxisome proliferator-activated receptor-alpha deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet: hyperinsulinemic-euglycemic clamp studies","volume":"145","author":"Haluzik","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.redox.2021.102152_bib50","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.redox.2021.102152_bib51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.redox.2021.102152_bib52","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1194\/jlr.M800248-JLR200","article-title":"Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice","volume":"49","author":"Minehira","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.redox.2021.102152_bib53","doi-asserted-by":"crossref","first-page":"G496","DOI":"10.1152\/ajpgi.00291.2013","article-title":"Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice","volume":"306","author":"Asai","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.redox.2021.102152_bib54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.gastro.2010.03.039","article-title":"Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia","volume":"139","author":"Amaro","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2021.102152_bib55","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/ATVBAHA.110.211789","article-title":"The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus","volume":"31","author":"Dekker","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.redox.2021.102152_bib56","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016310","article-title":"Association between atazanavir-induced hyperbilirubinemia and cardiovascular disease in patients infected with HIV","volume":"9","author":"Li","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.redox.2021.102152_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.redox.2021.102152_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007176.pub2","article-title":"Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases","author":"Bjelakovic","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.redox.2021.102152_bib59","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.2011.1437","article-title":"Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT)","volume":"306","author":"Klein","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.redox.2021.102152_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c5702","article-title":"Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials","volume":"341","author":"Sch\u00fcrks","year":"2010","journal-title":"Br. Med. J."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721003128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231721003128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:24:01Z","timestamp":1761978241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231721003128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":60,"alternative-id":["S2213231721003128"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2021.102152","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilirubin deficiency renders mice susceptible to hepatic steatosis in the absence of insulin resistance","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2021.102152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102152"}}